Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",27146,103,1.56 [1.06-2.30],0.0240922079630932
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",27698,145,0.84 [0.56-1.25],0.3827095675291524
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",27454,996,1.06 [0.92-1.23],0.4238558421381674
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Candidiasis,27732,300,0.92 [0.70-1.20],0.5273892631044383
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,26948,2730,0.97 [0.88-1.06],0.4470622459618617
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),27205,2051,1.05 [0.95-1.16],0.360740838410064
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,27521,994,0.94 [0.81-1.09],0.3840836082055043
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,27645,44,0.80 [0.38-1.67],0.5524223695381034
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,26480,622,0.95 [0.79-1.15],0.609925652283315
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,25614,608,1.13 [0.94-1.36],0.1765808612292445
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,25858,168,1.25 [0.89-1.74],0.1962857001309096
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,20659,1193,1.06 [0.92-1.21],0.4215159869944143
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,25611,282,1.11 [0.85-1.45],0.4528172923934759
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,27684,1157,0.93 [0.81-1.07],0.3044945462790388
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Mycoses,27791,359,0.98 [0.76-1.25],0.8546240291758103
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,27067,609,1.23 [1.03-1.47],0.0203554013012412
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,27731,688,1.07 [0.90-1.27],0.4508514307636824
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,26674,147,0.84 [0.56-1.25],0.3798328957295298
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,27833,32,0.79 [0.33-1.88],0.6000681456805542
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other septicaemia,27644,601,0.97 [0.80-1.17],0.7220297669941915
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,27673,72,0.89 [0.51-1.55],0.6801865489848868
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other viral diseases,27739,172,1.20 [0.87-1.67],0.2668243933135921
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",27723,156,1.12 [0.79-1.60],0.5244023419364343
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,26787,329,0.92 [0.71-1.19],0.518632908100262
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,26701,243,0.81 [0.59-1.11],0.1839951279047634
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,26607,80,1.50 [0.97-2.34],0.0688396490622946
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,27806,53,1.34 [0.76-2.37],0.318896398887357
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,27769,132,0.89 [0.59-1.35],0.5869879219589025
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Viral warts,27682,45,0.79 [0.39-1.64],0.532717611799369
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],27688,51,0.47 [0.23-0.99],0.0457766271686477
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign lipomatous neoplasm,27542,316,0.75 [0.57-0.99],0.0430742613314684
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,27743,77,0.75 [0.43-1.32],0.3202084216504985
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,27721,77,0.86 [0.50-1.49],0.5906499738872462
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,12400,44,1.00 [0.49-2.04],0.9987030789377752
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",27644,1167,0.83 [0.72-0.96],0.0123263188959569
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm of meninges,27821,49,1.14 [0.61-2.15],0.6779492047718522
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,27796,49,1.35 [0.75-2.42],0.3123404219928217
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,27812,95,0.95 [0.59-1.54],0.8385837437464572
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm of ovary,15370,99,0.64 [0.38-1.06],0.0815536559766371
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm: Ascending colon,27827,275,0.68 [0.51-0.92],0.0129262777377482
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm: Caecum,27823,206,0.65 [0.46-0.92],0.0157500305587367
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",27767,57,0.93 [0.50-1.74],0.8200705780684239
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm: Descending colon,27826,177,1.04 [0.74-1.47],0.8265885916241886
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm: Rectum,27791,285,0.94 [0.71-1.24],0.6568211871880245
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,27757,541,0.79 [0.64-0.97],0.0258852077136217
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm: Transverse colon,27826,305,0.78 [0.59-1.03],0.0840331155250418
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Carcinoma in situ of breast,13220,88,1.00 [0.61-1.64],0.9963035849355928
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",13267,101,0.80 [0.49-1.31],0.3806696134192527
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",24057,32,0.74 [0.31-1.78],0.5032600670622691
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",24061,36,1.55 [0.80-2.99],0.1955811674495071
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",27789,110,0.87 [0.55-1.38],0.5552134028046993
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Haemangioma, any site",27789,108,0.93 [0.59-1.47],0.7495599892522911
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Leiomyoma of uterus,14726,419,0.93 [0.74-1.17],0.5215137948771935
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Lung cancer and mesothelioma,20687,175,0.93 [0.64-1.34],0.6937519748154788
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Lymphoid leukaemia,24054,29,1.45 [0.71-2.99],0.3099910823680241
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",24173,148,0.80 [0.53-1.20],0.2751275474256285
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",24111,86,0.77 [0.45-1.32],0.3498712028265485
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",13320,81,1.31 [0.84-2.05],0.2376493903515234
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",24076,51,0.68 [0.34-1.37],0.2847545721454794
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",24088,63,0.89 [0.48-1.63],0.7042129190554112
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",24096,71,0.79 [0.44-1.43],0.4405760352440393
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",13293,54,0.90 [0.47-1.73],0.7529695509251824
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",24085,60,1.47 [0.88-2.46],0.142200795829203
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",11200,414,0.96 [0.76-1.21],0.7309165561678168
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",24116,91,0.89 [0.54-1.49],0.6671711546039295
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",24080,55,0.74 [0.38-1.44],0.370982823075987
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,24088,63,0.64 [0.34-1.21],0.1676944630096521
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Melanocytic naevi,27587,212,1.07 [0.78-1.46],0.6709000870588102
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Melanocytic naevi of trunk,27782,94,1.34 [0.88-2.03],0.1753238819941636
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Melanoma in situ,24041,51,0.41 [0.20-0.85],0.0171181084549894
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",24084,59,1.18 [0.66-2.13],0.5768072073844215
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",24142,117,1.27 [0.85-1.90],0.2345140403765851
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",24145,120,0.77 [0.49-1.22],0.2702143920620846
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",24094,69,1.24 [0.74-2.10],0.4161338580962525
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Other benign neoplasms of skin,27646,142,0.89 [0.60-1.33],0.5810503932137907
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",24671,646,0.85 [0.70-1.03],0.0899269550668755
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",24701,676,0.86 [0.71-1.04],0.1178912383891855
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,27567,285,0.92 [0.69-1.21],0.5452651529701955
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,26419,58,1.50 [0.89-2.52],0.1242032567976549
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,27351,69,0.93 [0.52-1.64],0.7962592844627712
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,27034,2237,0.99 [0.89-1.09],0.7731612181424843
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,26639,23,1.05 [0.40-2.79],0.919623370966864
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,27483,35,1.07 [0.49-2.32],0.8657743715751312
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,27389,1028,0.98 [0.84-1.13],0.7419212212806343
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,27389,1028,0.98 [0.84-1.13],0.7419212212806343
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,26418,57,1.00 [0.54-1.85],0.9980597793730274
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,27550,934,1.01 [0.87-1.17],0.9136192865673962
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,27560,112,1.11 [0.73-1.70],0.6243114801014101
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,27334,52,1.39 [0.80-2.41],0.2494439075153595
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,27324,42,0.36 [0.16-0.81],0.0133407159100399
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,27638,190,0.76 [0.53-1.09],0.1416610050945428
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,27751,71,1.27 [0.77-2.09],0.3427023212641426
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",27607,159,0.61 [0.41-0.91],0.0161745607182897
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,26690,74,1.05 [0.62-1.79],0.8627146513150404
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,23929,212,1.21 [0.90-1.64],0.2123047468359665
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,25906,127,0.71 [0.46-1.10],0.128953472207469
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,25915,136,0.74 [0.49-1.11],0.1476903406177118
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,23756,39,0.95 [0.44-2.01],0.8843107948743673
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,25841,71,0.99 [0.57-1.72],0.969656936460458
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,25508,153,0.73 [0.49-1.09],0.1236197051573392
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",27687,172,0.85 [0.59-1.23],0.3879309664102245
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,27562,47,1.04 [0.53-2.04],0.917336311636161
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,27551,36,0.90 [0.40-2.01],0.8000837419313899
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,27422,1652,0.95 [0.85-1.07],0.3758170611721103
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,24937,1604,0.95 [0.85-1.07],0.3933023832597453
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",23755,38,1.07 [0.51-2.23],0.8600362802614108
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",26140,57,0.75 [0.39-1.43],0.3748260894678686
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,23906,189,1.07 [0.76-1.49],0.7043004575176188
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,23777,60,1.94 [1.26-2.99],0.0025409077463354
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,26113,2396,1.07 [0.98-1.18],0.1351784150281672
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,23835,118,0.92 [0.59-1.43],0.723037922755988
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,24100,383,1.21 [0.96-1.51],0.1013650056693361
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,27728,278,0.90 [0.67-1.19],0.4570299927783624
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,27566,116,0.72 [0.46-1.15],0.1703471180158388
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,23811,94,1.17 [0.74-1.86],0.4951653588240103
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",23755,38,0.98 [0.46-2.09],0.9508561189995413
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,27405,1322,0.88 [0.77-1.00],0.051946958984431
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,23847,130,1.20 [0.81-1.77],0.3639117068520388
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,23883,166,1.05 [0.74-1.50],0.7803759605365335
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",24114,397,1.06 [0.84-1.34],0.6001508661098551
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,23777,60,0.92 [0.50-1.70],0.7949879071566693
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,27559,109,0.73 [0.45-1.17],0.1879185310151286
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,24014,297,0.76 [0.57-1.01],0.0574161370258207
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,24014,297,0.80 [0.60-1.06],0.1166097588154892
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,25414,59,0.89 [0.48-1.67],0.7237672316080621
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,27135,3418,1.02 [0.95-1.11],0.5466059637060456
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,26120,37,0.67 [0.29-1.53],0.3429909019315073
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,26145,62,0.72 [0.38-1.34],0.2983660734276025
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,27648,1935,0.89 [0.80-0.99],0.029028762990863
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",27653,1933,0.89 [0.80-0.99],0.0337309913839125
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,26120,37,1.15 [0.57-2.35],0.6961616132555732
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,27510,1255,0.93 [0.81-1.06],0.2600703129509591
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",24612,895,0.97 [0.83-1.14],0.7324181703095802
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,27823,135,1.01 [0.68-1.50],0.9427699658489644
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,27549,34,1.74 [0.95-3.20],0.074042641731857
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,26344,89,0.64 [0.37-1.09],0.097841401640903
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,26372,117,0.81 [0.51-1.27],0.3474720442105192
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",23852,135,0.99 [0.67-1.47],0.9591666884391474
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,26030,124,1.48 [1.03-2.13],0.034806335397502
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1715,70,0.92 [0.53-1.58],0.7509331368039849
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1827,197,0.77 [0.55-1.06],0.1113708822116108
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,25946,40,0.70 [0.31-1.56],0.3779926218125602
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1683,38,1.26 [0.67-2.37],0.479827884827761
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,27410,1504,1.25 [1.12-1.40],7.192739856077282e-05
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,27586,71,0.81 [0.45-1.44],0.4713824113739281
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,25631,276,0.65 [0.48-0.88],0.0051388061549948
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,24128,411,1.17 [0.94-1.46],0.151592172355034
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",27747,177,0.95 [0.67-1.35],0.773259265540656
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),27095,56,1.18 [0.64-2.17],0.5942936654555075
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Angina pectoris,26547,790,1.09 [0.93-1.29],0.282477306822557
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Aortic aneurysm,27143,104,1.06 [0.67-1.67],0.7944464198834692
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,27070,31,1.25 [0.55-2.80],0.59438473950653
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",27145,106,1.45 [0.97-2.17],0.0699325139351667
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,19868,939,1.00 [0.86-1.17],0.9493384884791164
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,AV-block,25350,184,0.95 [0.67-1.34],0.7599349418869975
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",27799,256,0.80 [0.59-1.08],0.1404220425762329
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Cardiac arrest,19042,113,1.10 [0.71-1.70],0.6685776014429876
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Cardiomyopathy,25302,136,0.78 [0.51-1.19],0.2457560598191425
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",25247,81,0.71 [0.41-1.23],0.2220312515538137
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,27835,20,0.82 [0.27-2.48],0.7268802968377381
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Conduction disorders,25695,529,1.03 [0.84-1.26],0.8016948469139564
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,27108,1362,1.10 [0.97-1.25],0.1247043618217451
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,25879,6053,1.02 [0.96-1.09],0.4415052948315716
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,DVT of lower extremities,26677,185,0.89 [0.63-1.27],0.5267227646501538
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Endocarditis,25210,44,0.78 [0.38-1.61],0.4964086591422986
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Heart failure, strict",27716,510,1.04 [0.84-1.27],0.739993041744492
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Hypertension,26457,4931,1.05 [0.98-1.12],0.162690858377642
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Hypertension, essential",26473,4947,1.05 [0.98-1.12],0.1429495863791151
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Hypertension, portal",27671,54,0.34 [0.17-0.70],0.003164447922644
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",21612,86,1.06 [0.64-1.74],0.8328337411945078
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,21593,67,1.48 [0.91-2.40],0.1157808190134701
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Hypotension,27731,683,1.11 [0.93-1.31],0.2542930150116799
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,27308,65,0.77 [0.42-1.42],0.407781120328486
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",27270,1513,1.09 [0.97-1.22],0.169059302157517
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",27604,302,1.26 [0.98-1.62],0.0660396943129757
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Left bundle-branch block,25358,192,1.07 [0.76-1.49],0.7082295588907138
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,27577,601,1.05 [0.87-1.27],0.6276990619396856
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",26246,489,1.03 [0.84-1.27],0.770743943412013
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",27777,119,0.89 [0.58-1.38],0.614449996189502
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",27820,206,0.82 [0.58-1.14],0.2386075232163796
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Oesophageal varices,26531,39,0.90 [0.42-1.92],0.7802536240089385
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other aneurysm,27087,48,0.62 [0.30-1.29],0.2006269189176785
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other arrhythmias,25403,237,0.84 [0.62-1.16],0.2912805515925096
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,27103,64,1.46 [0.86-2.48],0.1651165849431276
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,27180,141,0.84 [0.56-1.27],0.4136627491500269
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,25294,128,0.90 [0.59-1.37],0.6288454610577077
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other disorders of veins,26564,72,0.54 [0.29-0.98],0.0432726994444257
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,26539,47,1.20 [0.64-2.27],0.5673376735732696
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,27053,37,0.67 [0.29-1.53],0.3392657592040548
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,26580,88,1.18 [0.74-1.88],0.4831116519905374
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,25750,584,0.93 [0.77-1.13],0.4689773374675653
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,27095,47,0.71 [0.34-1.46],0.3506369963124797
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,27382,343,1.11 [0.87-1.41],0.4151723491034178
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,27383,154,1.19 [0.83-1.70],0.350168561482935
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",27253,237,1.17 [0.87-1.56],0.2961958290171765
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,19175,246,0.84 [0.62-1.15],0.2739319260448076
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Peripheral artery disease,27220,206,1.31 [0.97-1.77],0.0816783763383073
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),26748,256,0.94 [0.70-1.26],0.6671835442446423
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Pulmonary embolism,27571,342,1.06 [0.83-1.36],0.6369940688565283
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,27793,336,0.87 [0.67-1.13],0.3019677405984823
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Right bundle-branch block,25341,175,1.30 [0.94-1.79],0.112018957827362
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Secondary right heart disease,27379,150,1.21 [0.84-1.74],0.3136900555586126
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,27132,116,1.04 [0.68-1.60],0.8425138414822343
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",27597,354,1.18 [0.93-1.49],0.1735416553742246
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",27571,389,1.13 [0.90-1.42],0.2916974791025888
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,27284,54,0.61 [0.31-1.21],0.1600031949918717
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,27094,56,0.83 [0.43-1.58],0.5697003891950505
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Transient ischemic attack,27443,141,0.99 [0.67-1.47],0.9676018455330352
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,27158,182,1.03 [0.73-1.46],0.8459418880266498
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Varicose veins,26818,326,0.78 [0.60-1.03],0.0775082076587082
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,27048,49,1.31 [0.72-2.38],0.3760850937896336
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Venous thromboembolism,27663,538,1.05 [0.86-1.28],0.6112002372717293
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",27678,374,0.84 [0.66-1.08],0.1736160983116612
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",24828,1439,0.92 [0.81-1.04],0.1648392368895567
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,Any mental disorder,27084,3695,0.95 [0.88-1.03],0.2232511218584897
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",27616,444,0.87 [0.70-1.10],0.2473768789693523
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",25070,1681,0.96 [0.86-1.07],0.4583231236729367
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",23482,93,1.28 [0.83-1.99],0.2674116267439955
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,Smoking dependency,27301,1525,0.97 [0.86-1.09],0.6462325414678773
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",25161,1772,0.96 [0.86-1.07],0.4400522724826428
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,Vascular dementia,27719,20,0.59 [0.19-1.84],0.3617192926930741
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Alzheimer disease,27836,66,0.98 [0.55-1.76],0.957869611824468
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Bell's palsy,26158,73,0.69 [0.39-1.24],0.2125710999074926
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,26563,478,0.93 [0.75-1.15],0.4840513540589868
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Cerebral cysts,27482,207,0.88 [0.63-1.23],0.4491874401694761
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,27751,226,1.02 [0.75-1.39],0.9032181576413576
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,27694,24,0.79 [0.29-2.15],0.6379525366773388
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,27820,52,1.55 [0.91-2.65],0.1063614661486353
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",27335,60,1.27 [0.73-2.20],0.3954100428707768
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Epilepsy,26264,260,0.89 [0.66-1.20],0.4414766006450732
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,27350,1346,0.85 [0.75-0.97],0.0140410519363317
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,27806,268,1.10 [0.84-1.46],0.489356403040405
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Falls/tendency to fall,27315,1654,0.88 [0.78-0.99],0.030792907641955
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Generalized epilepsy,27467,53,0.61 [0.30-1.22],0.1584819537890152
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Hemiplegia,27687,162,1.07 [0.74-1.53],0.7268662479962665
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Hydrocephalus,27321,46,1.01 [0.51-2.01],0.967990687270133
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,27811,65,0.99 [0.55-1.77],0.9731737986292244
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,26164,79,0.63 [0.36-1.12],0.1154245444114377
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,26172,87,1.28 [0.82-2.01],0.2829861338777664
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Memory loss,27683,73,1.07 [0.63-1.82],0.8032824567577261
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Migraine,26425,421,0.82 [0.65-1.04],0.1007357250279051
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",27745,374,0.76 [0.59-0.98],0.0345167008694539
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Motor neuron disease,20284,96,1.26 [0.82-1.94],0.2942308065772547
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,27641,145,0.92 [0.62-1.35],0.6577532311095283
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",27222,1137,0.90 [0.78-1.03],0.1257582271983301
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Neurological diseases,26404,3088,0.90 [0.83-0.98],0.0155485000162607
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,27742,72,0.73 [0.40-1.30],0.2824619853080031
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",26477,392,0.91 [0.72-1.16],0.4436106254936733
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",27766,235,1.02 [0.76-1.38],0.8799071761508199
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,23235,308,0.82 [0.62-1.09],0.1696181599699172
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,27335,60,0.81 [0.43-1.52],0.5104939504353024
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other disorders of nervous system,27385,110,0.97 [0.62-1.52],0.9008312730442084
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,27628,90,1.19 [0.75-1.90],0.4646091114811863
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other facial nerve disorders,26175,90,0.68 [0.40-1.15],0.1500321311148167
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other headache syndromes,26064,60,0.56 [0.29-1.07],0.0769478739112037
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other neurological diseases,27714,439,0.98 [0.78-1.22],0.8349398019857138
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other sleep disorders,26591,587,0.90 [0.74-1.09],0.2877999704594224
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Parkinson's disease,27823,157,0.91 [0.62-1.33],0.6262779701647969
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,27339,64,0.64 [0.34-1.21],0.1710168595398267
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Restless leg syndrome,27834,44,1.70 [1.00-2.88],0.0488380072397562
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Sleep apnoea,27588,513,0.94 [0.76-1.15],0.543978389525563
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Small fibre neuropathy,27568,37,0.81 [0.36-1.80],0.603831131467527
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,27821,121,1.21 [0.81-1.80],0.3475467463398697
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,26117,32,0.46 [0.18-1.16],0.1003248788250338
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,27836,67,0.99 [0.56-1.76],0.978736484648324
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),27706,19,0.46 [0.14-1.53],0.2057844956130617
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,27349,43,0.89 [0.42-1.87],0.757872681515243
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,27482,214,0.68 [0.48-0.96],0.0269804581503626
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,27745,198,0.89 [0.64-1.25],0.5151877137438903
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,27087,37,1.22 [0.60-2.47],0.585148704036591
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,27127,77,1.49 [0.96-2.30],0.0739347312776564
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",27745,30,1.94 [1.11-3.39],0.0190980442012358
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,27633,65,1.08 [0.61-1.91],0.7937092395218661
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1690,45,1.18 [0.64-2.15],0.5953539813275427
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1998,85,0.97 [0.60-1.58],0.9181198853224816
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,27386,80,0.72 [0.42-1.26],0.2532776646554127
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,27706,615,0.87 [0.72-1.06],0.1679680484270591
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",27531,481,0.94 [0.76-1.16],0.5549928693917627
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,27187,137,0.99 [0.67-1.48],0.9719664416232258
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",27742,474,0.82 [0.65-1.02],0.0781542663737336
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,27822,52,2.04 [1.37-3.04],0.0004576724309607
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,27668,400,0.76 [0.59-0.97],0.0285720674386714
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",27791,223,1.25 [0.93-1.67],0.1342471383557665
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,27774,125,0.94 [0.62-1.45],0.7900016396704608
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,27068,18,1.62 [0.66-3.96],0.2924817491771385
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,27077,27,0.86 [0.34-2.20],0.756304755760905
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,27082,32,1.38 [0.67-2.83],0.3773409793866231
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,27786,391,0.86 [0.67-1.10],0.2288281201934573
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,27497,102,0.97 [0.60-1.54],0.8847240288752913
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,27294,26,1.00 [0.40-2.51],0.9996699959162638
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,27642,74,1.28 [0.78-2.12],0.3322919910486073
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,27717,149,1.18 [0.82-1.70],0.3643782872011646
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,27429,161,0.93 [0.64-1.36],0.7191892651136786
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,27723,74,1.01 [0.59-1.74],0.961157287806499
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,27657,262,0.86 [0.63-1.16],0.3105010006627413
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,27425,119,1.52 [1.06-2.16],0.0210182201799802
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,27121,1057,1.04 [0.90-1.19],0.6354429820623222
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,27691,123,1.20 [0.81-1.78],0.3694843517307105
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,27810,113,0.75 [0.47-1.20],0.2282196885028857
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,27314,264,0.88 [0.66-1.19],0.4137025894786412
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,27604,36,1.24 [0.59-2.59],0.5729430972586976
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,27805,35,2.21 [1.44-3.39],0.0002807205464719
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,27089,39,1.87 [1.14-3.08],0.0134556851686291
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,27166,116,0.69 [0.43-1.09],0.1129964969547365
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,27162,71,0.90 [0.51-1.59],0.7130053109184056
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,27329,61,1.10 [0.62-1.95],0.7505233771333595
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",27140,49,0.51 [0.24-1.06],0.0714802564007297
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,27450,55,1.02 [0.54-1.91],0.9610375462440456
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",27487,92,0.94 [0.57-1.55],0.7983293372273086
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,27142,92,1.15 [0.72-1.83],0.5623953731246755
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,27215,124,0.76 [0.49-1.18],0.2248043649488806
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,27125,34,1.15 [0.53-2.46],0.725759159978077
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,26898,834,0.85 [0.71-1.00],0.052463582824399
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,27100,50,0.96 [0.49-1.87],0.9002446583936196
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,27620,314,1.14 [0.88-1.46],0.3219827484211442
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,27343,37,1.19 [0.58-2.45],0.6349159525637034
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),27432,126,1.03 [0.68-1.55],0.9058763198263624
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,27640,61,0.79 [0.42-1.48],0.464772328001018
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,27793,96,0.57 [0.34-0.95],0.032913120950402
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,27717,135,0.76 [0.50-1.17],0.2121875494240105
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,27633,54,1.18 [0.65-2.15],0.5790643267968022
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,27632,53,0.94 [0.50-1.80],0.8629585047175423
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,27745,533,0.96 [0.78-1.18],0.7045036541009893
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,27545,333,1.07 [0.83-1.38],0.5897250937239427
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,27307,95,0.75 [0.45-1.26],0.27699571885623
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,27289,77,0.81 [0.46-1.41],0.4501024343446198
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Acute pharyngitis,27547,80,0.99 [0.59-1.66],0.9806772685469336
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,27699,232,0.84 [0.61-1.15],0.2853383625191376
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,27527,60,0.97 [0.53-1.76],0.9121239801968754
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,All influenza,26525,78,1.32 [0.82-2.12],0.2537412299061906
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),26523,76,1.30 [0.80-2.11],0.2936637127173893
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Allergic asthma (mode),20639,127,0.94 [0.62-1.41],0.7506939501727953
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Allergic rhinitis,27680,317,0.94 [0.72-1.22],0.6212903970888848
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",22148,1777,0.93 [0.83-1.04],0.2156313411487292
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",22261,1749,0.93 [0.83-1.04],0.2067708104212273
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),27549,94,1.38 [0.91-2.11],0.1327949060882892
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",26505,58,1.60 [0.98-2.61],0.0613645884080262
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Bronchiectasis,24775,184,1.01 [0.72-1.43],0.9394913863223018
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",24634,43,0.78 [0.37-1.64],0.5202960000238764
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,26964,2373,0.99 [0.90-1.09],0.7998166996918672
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",26339,64,0.89 [0.49-1.62],0.7100232008076881
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Chronic sinusitis,26446,171,1.30 [0.94-1.79],0.1111017335983628
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",27728,721,1.15 [0.97-1.37],0.0987631263877375
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Deviated nasal septum,26405,130,0.79 [0.52-1.21],0.2794581457856832
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,25906,4292,0.99 [0.93-1.07],0.8421870919959931
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",26657,382,0.93 [0.73-1.18],0.5321698699403359
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Early onset COPD,27515,508,1.22 [1.00-1.48],0.050181939046444
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Emphysema,24776,185,1.17 [0.84-1.64],0.3401723410669408
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,26578,115,1.36 [0.93-2.00],0.1152989405931111
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Influenza and pneumonia,27653,1206,0.98 [0.86-1.13],0.81697570445693
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Interstitial lung disease,26603,140,1.26 [0.88-1.81],0.2087259792684107
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Later onset COPD,26391,213,1.02 [0.73-1.42],0.9122041091453004
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,27827,156,1.01 [0.69-1.47],0.9749847527974318
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Nasal polyp,26386,111,1.03 [0.66-1.59],0.9100054613638696
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,27623,621,1.04 [0.87-1.25],0.6746700364601483
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other diseases of pleura,27657,1250,1.04 [0.91-1.19],0.5496983283720922
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,27177,902,0.98 [0.84-1.15],0.8109835028673619
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other pleural conditions,26442,35,1.07 [0.49-2.34],0.859273404712188
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,27778,198,1.22 [0.89-1.66],0.2108093443276297
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,27751,851,1.06 [0.91-1.24],0.4457673284221005
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Pleural effusion,27005,598,1.05 [0.87-1.27],0.5912815179951674
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Pleural plaque,26464,57,0.99 [0.52-1.87],0.9750092323865523
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",27443,996,1.02 [0.88-1.18],0.8342645799170492
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,27807,136,0.97 [0.65-1.46],0.8912096206155897
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Pneumothorax,26471,64,1.12 [0.63-1.98],0.6923211197794816
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Pollen allergy,27800,271,0.94 [0.71-1.25],0.6757580619457733
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Pulmonary oedema,27618,38,1.15 [0.55-2.39],0.7066936530276899
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Respiratory insufficiency,20550,38,0.54 [0.24-1.24],0.145988622318567
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,27603,601,1.05 [0.87-1.26],0.6378559078723023
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,26592,317,0.93 [0.72-1.22],0.6074172397436371
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Viral pneumonia,26641,194,0.81 [0.57-1.14],0.2224497375894472
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",27568,168,0.77 [0.53-1.12],0.1688175540421823
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,16076,104,1.07 [0.68-1.67],0.7734799017900948
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,21326,65,0.90 [0.50-1.63],0.7378778713577565
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Acute appendicitis,27633,159,0.88 [0.60-1.29],0.5068981527395788
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Acute gastritis,22258,75,0.74 [0.42-1.32],0.3133198059585746
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Acute pancreatitis,26237,165,0.98 [0.68-1.41],0.901303761214976
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Acute peritonitis,27401,74,0.71 [0.40-1.26],0.2363288462777118
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Alcoholic liver disease,27047,79,0.65 [0.37-1.15],0.1388361971035701
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Barrett oesophagus,22534,351,0.70 [0.54-0.91],0.008533034816046
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",26125,53,1.48 [0.87-2.53],0.1523176146513395
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",27428,53,1.48 [0.87-2.54],0.1517882278102964
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Cholecystitis,26253,181,1.34 [0.98-1.83],0.0659253332299449
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Cholelithiasis,26979,907,0.81 [0.69-0.96],0.012292649417624
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Chronic gastritis,22442,259,1.15 [0.87-1.51],0.3194601885909466
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Chronic pancreatitis,26116,44,1.11 [0.57-2.19],0.7565583207649764
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",27694,77,0.86 [0.49-1.49],0.5908085081492036
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Coeliac disease,26407,118,1.13 [0.75-1.70],0.5562148596115962
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Collagenous colitis,26251,58,1.55 [0.96-2.49],0.0746837750274125
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,27654,209,1.10 [0.81-1.50],0.5485730119499632
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Constipation,27614,1185,0.99 [0.86-1.13],0.8566983118085294
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Crohn disease,26290,97,1.07 [0.67-1.70],0.7746241479059173
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",27490,68,0.98 [0.56-1.73],0.9531035016776072
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Crohn's disease NAS,26287,94,1.06 [0.67-1.70],0.7967142157528698
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Dental caries,26993,265,0.99 [0.75-1.31],0.9441606393714445
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,25750,1840,0.86 [0.77-0.97],0.0103896992439312
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of appendix,27676,202,0.96 [0.69-1.33],0.807418064113677
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of liver,27717,749,1.12 [0.95-1.32],0.1633934991297041
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",26106,3923,0.96 [0.89-1.04],0.3426339373059741
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",27344,616,1.05 [0.87-1.26],0.605584200116584
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of peritoneum,27757,430,1.00 [0.80-1.25],0.9857768044075056
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,26861,133,0.83 [0.55-1.25],0.3715850302708858
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of salivary glands,26698,71,0.78 [0.44-1.38],0.3929235929377404
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of the digestive system,27556,1267,1.07 [0.94-1.22],0.2860233487368239
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of tongue,26709,122,0.98 [0.64-1.49],0.9096516672074882
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",27317,1245,0.94 [0.83-1.08],0.3945716924341272
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,23720,2459,1.00 [0.91-1.10],0.9620300640910618
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Duodenal ulcer,22327,144,1.36 [0.96-1.92],0.0848866284608959
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",27763,113,1.36 [0.92-2.01],0.1287745936674043
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,27697,81,1.09 [0.66-1.80],0.7266298380083287
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,27066,98,1.10 [0.69-1.76],0.6780594507138116
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,21441,180,1.10 [0.79-1.54],0.5693303069034227
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Functional dyspepsia,22700,517,0.88 [0.71-1.09],0.2306447170609389
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Gastric ulcer,22466,283,1.00 [0.75-1.32],0.976519639155832
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,24456,2273,0.93 [0.84-1.02],0.1273141214465533
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,22592,409,1.16 [0.93-1.44],0.1935576602396936
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,22748,8159,0.96 [0.91-1.01],0.124940328046542
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,GI-bleeding,27309,1020,1.08 [0.94-1.25],0.2669960669412712
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,26791,63,0.96 [0.54-1.72],0.9030647975838038
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,22202,1307,0.94 [0.82-1.07],0.3334931494811319
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",27024,56,1.14 [0.62-2.09],0.6701334799398755
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Hernia,26679,2769,0.87 [0.79-0.95],0.002809937826918
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Impacted teeth,27706,75,1.18 [0.71-1.96],0.5144489028811348
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Impaction of intestines,21293,32,0.68 [0.28-1.65],0.3992234827392394
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Inguinal hernia,24596,686,0.92 [0.76-1.10],0.3525042482666551
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",23986,76,1.05 [0.61-1.80],0.8574772643966894
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,21332,71,1.12 [0.66-1.91],0.6625079930402165
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Intestinal malabsorption,26428,139,1.08 [0.73-1.58],0.70899489270777
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,21836,575,0.88 [0.72-1.07],0.1939033099147407
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,27809,393,1.27 [1.02-1.57],0.0322206303926632
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,26906,713,0.93 [0.78-1.12],0.4556678473673342
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,27092,899,0.87 [0.74-1.02],0.0930139602230697
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Oesophageal obstruction,22334,151,0.95 [0.65-1.40],0.8077103089321992
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Oesophagitis,22676,493,0.84 [0.67-1.04],0.1121840513285185
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,27791,136,1.00 [0.68-1.48],0.9922963881559776
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,23959,49,0.99 [0.51-1.91],0.9734744817766388
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,22563,1302,0.93 [0.82-1.06],0.3066868292705236
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,26267,195,1.08 [0.78-1.50],0.625201874772343
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,26234,162,0.85 [0.58-1.24],0.3995772433072697
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of intestine,22766,1505,0.92 [0.81-1.04],0.1817631693259388
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of intestines,26193,4932,0.97 [0.91-1.04],0.3931586274295333
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,26703,202,1.09 [0.80-1.49],0.5867479323855624
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of liver,27575,607,1.13 [0.94-1.36],0.1804157141730075
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,22723,540,0.76 [0.62-0.94],0.0120708175424537
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of pancreas,26156,84,0.70 [0.41-1.20],0.1949281418620017
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,27700,373,1.00 [0.79-1.27],0.9938700494375308
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,22973,790,0.84 [0.70-0.99],0.0422610291182159
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,27323,1034,1.08 [0.94-1.25],0.272230603494151
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,26917,189,1.05 [0.76-1.46],0.7577461708631963
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,22490,1229,0.96 [0.84-1.09],0.5116704120325515
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),23976,1793,0.95 [0.85-1.06],0.3654095068839998
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,27049,81,0.81 [0.47-1.38],0.4347588382511292
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,26978,785,0.91 [0.77-1.08],0.2681426989146894
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",21496,235,0.84 [0.61-1.15],0.2742989508970581
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,27681,95,1.02 [0.63-1.63],0.941969478427252
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,21612,351,0.90 [0.70-1.17],0.4388790024993986
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",26423,134,0.92 [0.61-1.38],0.682226488861853
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Recurring oral aphthae,27826,61,1.11 [0.63-1.97],0.7107985090705861
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,26747,133,1.22 [0.84-1.78],0.2904762892364179
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Toxic colitis,26225,32,0.60 [0.25-1.47],0.2652783149155364
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,22363,180,0.74 [0.51-1.07],0.1082428923721946
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Ulcerative colitis,26339,146,1.01 [0.69-1.49],0.962344474557308
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",26318,125,1.06 [0.70-1.60],0.7912440844107187
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Umbilical hernia,24196,286,0.87 [0.66-1.15],0.3146049116467045
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,21365,104,0.91 [0.57-1.46],0.6969878093468069
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Ventral hernia,24140,230,0.78 [0.56-1.07],0.1242164102578567
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Volvulus,21325,64,0.90 [0.49-1.64],0.7334799007280092
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,27779,159,1.20 [0.85-1.70],0.3096594089738979
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,27562,81,0.74 [0.43-1.28],0.2872246737181033
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,26334,149,1.01 [0.69-1.48],0.9531370242807952
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,27206,549,1.07 [0.88-1.30],0.4999162437520548
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",26855,198,0.75 [0.53-1.06],0.1074264170399096
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,26365,180,0.84 [0.58-1.20],0.3291702111159481
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,27577,233,1.41 [1.09-1.84],0.0098718711589487
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,27737,393,1.18 [0.94-1.47],0.1457877605395834
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,27392,48,0.92 [0.46-1.83],0.8130494843741309
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,26360,2590,0.97 [0.89-1.07],0.5562642148869019
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,27379,442,0.98 [0.79-1.23],0.8921199747947045
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,27253,316,0.93 [0.71-1.21],0.567888001928098
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,27441,784,1.02 [0.87-1.21],0.7775870276253202
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",27822,47,0.96 [0.49-1.90],0.9120828454123115
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,26240,55,1.13 [0.62-2.07],0.6953143006271174
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,26977,40,0.99 [0.47-2.06],0.9695302228138096
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,27571,227,1.39 [1.06-1.82],0.0157692957259443
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,26477,292,0.84 [0.63-1.12],0.2283695496043236
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,26222,37,1.27 [0.63-2.53],0.5019330425665604
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,27754,69,1.03 [0.59-1.80],0.9126743514566305
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,26794,137,1.24 [0.86-1.80],0.2516645145090976
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,27638,157,0.93 [0.64-1.36],0.7163417713696898
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,27376,32,0.93 [0.40-2.14],0.8618251466907895
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,26237,52,0.97 [0.50-1.88],0.9302939661001411
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,27304,1119,0.93 [0.81-1.08],0.34279663454912
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",26508,323,0.88 [0.67-1.14],0.3337633858911599
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,26226,41,1.14 [0.57-2.27],0.7125103005918504
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,27752,271,0.87 [0.65-1.16],0.3414030340757972
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,27403,59,0.78 [0.41-1.48],0.442285622250342
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,27704,223,0.85 [0.62-1.17],0.3246591864137409
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,27802,182,1.09 [0.78-1.53],0.6026696981548709
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,26308,123,0.84 [0.54-1.30],0.4275126394116786
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,26376,191,0.83 [0.58-1.19],0.3090770430678982
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,27793,173,1.08 [0.76-1.53],0.6632705788826283
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",26317,132,1.36 [0.94-1.96],0.100104547163308
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,27802,117,1.00 [0.65-1.54],0.9948042194910958
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,24436,138,0.76 [0.50-1.15],0.192573150087159
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,25995,4708,0.91 [0.85-0.97],0.0068432337682205
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,24609,3322,0.86 [0.79-0.94],0.0005466262643323
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,24394,96,1.23 [0.79-1.90],0.3568137498295046
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,24970,156,1.12 [0.78-1.61],0.5309159614122814
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,24978,164,1.06 [0.74-1.51],0.7617253481614777
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,27606,117,0.83 [0.53-1.29],0.4094689347110726
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",24862,48,0.66 [0.32-1.37],0.2645088613987921
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,22041,754,0.89 [0.75-1.06],0.2019396231273592
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",27776,122,1.50 [1.05-2.12],0.0240949612850768
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,25109,295,0.88 [0.66-1.16],0.3691367402566952
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,24351,6311,0.93 [0.88-0.99],0.0271832189448832
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,26446,107,0.83 [0.52-1.33],0.4405108679142887
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,24416,118,0.94 [0.61-1.46],0.7905343949149162
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,24913,615,0.98 [0.82-1.19],0.8671395875690527
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,26940,2126,0.94 [0.85-1.04],0.2118973599640858
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,24522,224,0.95 [0.69-1.29],0.7253422224567099
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,24584,286,0.84 [0.63-1.12],0.2303231793943345
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,24448,150,1.10 [0.76-1.59],0.6106164577698499
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,27316,36,1.06 [0.50-2.26],0.8732989275919519
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,22617,1330,0.82 [0.72-0.93],0.002993914076039
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,21684,397,1.14 [0.91-1.43],0.2415843974850486
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",27781,388,1.23 [0.98-1.54],0.0697703125827925
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,21358,71,0.72 [0.40-1.31],0.2878400057526252
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),21635,348,0.77 [0.59-1.00],0.0513404888969346
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,24634,336,0.91 [0.71-1.18],0.4968834668988292
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,22062,775,0.90 [0.76-1.07],0.2219765073808842
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,24843,29,0.68 [0.27-1.74],0.426584369667342
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,25375,561,1.00 [0.82-1.22],0.9732218336003606
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,25100,286,0.99 [0.75-1.30],0.925282695649335
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,22011,724,0.88 [0.74-1.05],0.1579780338719328
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,24384,86,1.12 [0.69-1.81],0.6513202514139155
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",24361,63,0.65 [0.35-1.23],0.185620668308991
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,26398,59,1.18 [0.66-2.09],0.5785335473579512
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,27498,1159,0.87 [0.75-1.00],0.0508851445901406
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,26995,656,0.85 [0.70-1.02],0.0879462158670672
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",27727,353,1.20 [0.95-1.51],0.1297497445981376
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,23079,1792,0.87 [0.77-0.97],0.0153084971733414
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,21368,81,0.89 [0.53-1.52],0.6768320924542621
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,24375,77,1.34 [0.84-2.14],0.2193279063744603
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,21314,27,1.46 [0.66-3.23],0.3494020916996709
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),21400,113,0.63 [0.39-1.02],0.0586086715689473
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,26571,232,0.76 [0.55-1.04],0.0896405850094299
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,26584,245,1.06 [0.79-1.42],0.7123082797952063
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,27793,83,0.85 [0.50-1.44],0.5355653057429265
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",26400,1586,0.96 [0.85-1.07],0.4461776037521142
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,24421,123,0.97 [0.64-1.47],0.8947528425245888
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),21401,114,0.44 [0.27-0.72],0.0009686396388495
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,25454,640,1.03 [0.86-1.24],0.7366199888721409
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,23346,2059,0.84 [0.76-0.94],0.0016485364506896
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,27340,60,1.16 [0.66-2.05],0.6106553338353929
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,27810,77,0.82 [0.47-1.42],0.4810340964248755
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,24383,85,1.33 [0.85-2.07],0.2153060280241999
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",25405,1107,0.93 [0.81-1.07],0.3268339372489433
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,24367,69,1.22 [0.72-2.07],0.4549593045722749
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,22426,1139,0.98 [0.86-1.13],0.817671794711885
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,26439,100,0.66 [0.40-1.09],0.104448086307917
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,24365,67,0.99 [0.57-1.75],0.9851300206756656
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,24930,116,0.53 [0.33-0.85],0.0083664516969981
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,24703,405,1.10 [0.88-1.37],0.4177286634183637
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,27487,207,1.09 [0.80-1.49],0.5814000908298942
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,25288,474,1.04 [0.84-1.28],0.7360099754534968
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,27734,332,1.21 [0.95-1.53],0.1170910823350742
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,27817,37,1.35 [0.69-2.65],0.3743476145238227
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,24507,209,0.90 [0.64-1.24],0.5100352341111621
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,22342,606,0.80 [0.66-0.98],0.0272028942384069
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,24795,497,0.93 [0.75-1.15],0.5187701287545898
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],24467,169,0.96 [0.67-1.38],0.8154498017808299
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",21324,37,1.12 [0.54-2.32],0.7701303111424982
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,23084,1797,1.03 [0.92-1.14],0.6502634663836769
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,21750,463,0.85 [0.67-1.06],0.1433677172411656
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,27366,86,1.42 [0.92-2.18],0.1125530568323854
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",27761,51,0.89 [0.45-1.76],0.7473554510557441
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",26209,30,0.71 [0.29-1.75],0.459711415326529
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,21366,79,0.75 [0.43-1.31],0.317490175714287
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,24903,89,0.73 [0.43-1.23],0.2359101186535777
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,21643,356,1.12 [0.88-1.43],0.3416651755192912
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,24570,272,0.83 [0.62-1.11],0.2025012714258354
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,25033,219,0.85 [0.61-1.17],0.3184948385877436
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,24920,106,0.89 [0.56-1.42],0.6302706128291324
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,23566,50,1.41 [0.82-2.45],0.2165593393781519
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",27820,40,1.33 [0.69-2.55],0.3966686621327323
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,24910,612,0.95 [0.78-1.15],0.5828019097566126
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],27366,86,0.88 [0.52-1.48],0.6171978076921127
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,26733,2435,0.93 [0.85-1.03],0.1514711353545843
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",24409,111,0.57 [0.36-0.93],0.0238027191846262
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,25176,362,0.93 [0.72-1.20],0.5715793367392878
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,26430,188,0.67 [0.47-0.97],0.0315451320003609
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,24967,153,0.75 [0.50-1.13],0.1694446844030895
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,25890,1076,0.99 [0.86-1.15],0.9296873943521198
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,25536,722,1.12 [0.95-1.33],0.1844671449915861
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],24342,44,1.62 [0.94-2.79],0.0798205441783548
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,27426,146,0.68 [0.45-1.03],0.0679861071005949
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,24457,159,0.94 [0.65-1.37],0.7596389076648525
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,24357,59,0.68 [0.35-1.29],0.2380906573972919
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),21324,37,0.54 [0.23-1.24],0.1460376128160343
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Acute renal failure,27265,866,1.12 [0.96-1.30],0.1593175009443219
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),11301,75,1.27 [0.78-2.06],0.3400621485481906
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,15039,77,1.04 [0.62-1.75],0.8882115878142235
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,27538,321,1.05 [0.81-1.35],0.720571667921833
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,27276,59,0.78 [0.41-1.47],0.4357778890990179
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,27105,706,1.11 [0.94-1.32],0.2202296084980271
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,27644,33,1.47 [0.74-2.91],0.2727505359162812
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,27655,190,0.96 [0.68-1.35],0.8046179862333904
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Cystitis,25619,165,0.61 [0.41-0.91],0.0151743177272803
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Dialysis,26463,64,1.50 [0.93-2.42],0.0948927004847167
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,12009,1144,0.94 [0.81-1.08],0.3697064453766949
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Disorders of breast,15169,207,0.96 [0.70-1.34],0.8287368256726168
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Endometriosis,11366,140,0.96 [0.65-1.42],0.825837438060169
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",11622,396,0.78 [0.61-1.00],0.0476814207398779
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,11655,429,0.83 [0.66-1.05],0.1170169584702612
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,23469,4317,0.94 [0.87-1.01],0.0731636115219749
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,27682,71,1.32 [0.81-2.14],0.2699707770474713
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Hydrocele,10954,89,1.04 [0.63-1.70],0.8776697233977474
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,26312,225,1.21 [0.90-1.61],0.2063745294331979
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,11620,755,0.94 [0.79-1.12],0.4593626868273224
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,15030,245,0.78 [0.57-1.06],0.1142174282873953
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),10973,108,1.53 [1.03-2.28],0.0342314888491851
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Irregular menses,15037,127,0.56 [0.35-0.87],0.0101793709578546
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Menorrhagia,11530,304,0.79 [0.60-1.05],0.0993853965471449
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,25520,66,0.82 [0.45-1.49],0.5143597263580985
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,12665,1439,0.89 [0.78-1.00],0.0565071611994626
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,10914,49,0.59 [0.29-1.21],0.1501309291669825
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,11331,105,0.64 [0.40-1.05],0.0770531216651005
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",27823,36,0.67 [0.29-1.54],0.3419658397012011
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",27830,48,0.63 [0.31-1.31],0.2210668032384357
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,26965,1511,0.91 [0.81-1.03],0.1441792581500929
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,25921,467,0.74 [0.59-0.93],0.010591101955479
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,15030,68,0.77 [0.42-1.40],0.3939422272943397
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,27782,317,1.17 [0.91-1.50],0.2284755868427383
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,11020,155,0.57 [0.38-0.85],0.006590286512677
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,10984,119,1.16 [0.76-1.77],0.4892237186993678
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,10941,76,0.68 [0.38-1.21],0.1852031226896417
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,27798,55,1.13 [0.62-2.05],0.681018530205147
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,26545,1091,0.94 [0.81-1.08],0.3783223983469909
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,14913,128,0.87 [0.57-1.32],0.4999415498983288
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,11311,85,0.66 [0.39-1.13],0.1269870187142316
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",11457,231,0.62 [0.45-0.86],0.0044305293458166
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,11286,60,0.86 [0.46-1.60],0.6351182961355124
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,11332,106,0.65 [0.40-1.06],0.0822783840318108
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,26344,257,1.16 [0.88-1.52],0.3019254118320061
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,27578,113,1.53 [1.06-2.22],0.0244703152057557
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,11413,187,0.79 [0.55-1.13],0.1978316934022759
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,11309,83,0.72 [0.42-1.24],0.2347825827563119
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,11668,442,0.97 [0.78-1.21],0.7799443744131396
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,11295,69,0.78 [0.43-1.39],0.3937090863005669
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,11612,386,1.06 [0.85-1.33],0.6032524058823768
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,27659,48,1.53 [0.88-2.67],0.1341780594947454
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",10971,106,1.14 [0.73-1.79],0.5633450106968303
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,27629,1542,1.04 [0.92-1.16],0.5617979388615598
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",26230,143,1.26 [0.88-1.79],0.2108087212830472
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,26478,79,0.87 [0.51-1.50],0.6230638962203616
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,27290,73,1.16 [0.69-1.96],0.5714316231016835
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Urethral stricture,25624,170,1.00 [0.70-1.44],0.979051017210853
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Urolithiasis,27602,385,1.06 [0.84-1.34],0.6266817345354166
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Uterine polyps,11334,108,1.25 [0.84-1.88],0.2745535880363585
